Showing 1 - 1 of 1 Kidney Cancers

Status: Open Not Enrolling

Investigator: Kirk Heyne

Study Coordinator:


This is a multicenter Phase 1b, open-label study to assess safety, tolerability, preliminary efficacy, and pharmacokinetics (PK) of cabozantinib taken in combination with atezolizumab in subjects with multiple tumor types, including advanced uro ... Read more >